EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Expanding the Substrate Selectivity of the Fimsbactin Biosynthetic Adenylation Domain, FbsH

Syed Fardin Ahmed iD, Adam Balutowski, Jinping Yang iD, Timothy A Wencewicz iD, Andrew M Gulick iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.4c00512 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Syed Fardin Ahmed and 4 co-authors. Institution: Department of Structural Biology, University at Buffalo, Buffalo, New York 14203, United States. Major MEDLINE topics: Acinetobacter baumannii, Peptide Synthases, Siderophores. Cited 9 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIGMS NIH HHS, Division of Chemistry, National Science Foundation Graduate Research Fellowship Program.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Nonribosomal peptide synthetases (NRPSs) produce diverse natural products including siderophores, chelating agents that many pathogenic bacteria produce to survive in low iron conditions. Engineering NRPSs to produce diverse siderophore analogs could lead to the generation of novel antibiotics and imaging agents that take advantage of this unique iron uptake system in bacteria. The highly pathogenic and antibiotic-resistant bacteria Acinetobacter baumannii produces fimsbactin, an unusual branched siderophore with iron-binding catechol groups bound to a serine or threonine side chain. To explore the substrate promiscuity of the assembly line enzymes, we report a structure-guided investigation of the stand-alone aryl adenylation enzyme FbsH. We report structures bound to its native substrate 2,3-dihydroxybenzoic acid (DHB) as well as an inhibitor that mimics the adenylate intermediate. We produced enzyme variants with an expanded binding pocket that are more tolerant for analogs containing a DHB C4 modification. Wild-type and mutant enzymes were then used in an in vitro reconstitution analysis to assess the production of analogs of the final product as well as several early stage intermediates. This analysis shows that some altered substrates progress down the fimsbactin assembly line to the downstream domains. However, analogs from alternate building blocks are produced at lower levels, indicating that selectivity exists in the downstream catalytic domains. These findings expand the substrate scope of producing condensation products between serine and aryl acids and identify the bottlenecks for chemoenzymatic production of fimsbactin analogs.

Subjects

MeSH terms (MEDLINE)

Acinetobacter baumanniiPeptide SynthasesSiderophoresSubstrate SpecificityBacterial ProteinsHydroxybenzoates

Substances

Peptide SynthasesSiderophoresBacterial ProteinsHydroxybenzoates2,3-dihydroxybenzoic acidnon-ribosomal peptide synthase

Authors and institutions

  • Department of Structural Biology, University at Buffalo, Buffalo, New York 14203, United States.
  • Department of Chemistry, Washington University in St. Louis, St. Louis, Missouri 63130, United States.

ORCID profiles: Syed Fardin Ahmed, Jinping Yang, Timothy A Wencewicz, Andrew M Gulick

Funding

  • NIGMS NIH HHS
  • Division of Chemistry
  • National Science Foundation Graduate Research Fellowship Program
  • College of Arts and Sciences, Washington University in St. Louis
  • National Institute of General Medical Sciences

Cite

APA

Ahmed, S. F., Balutowski, A., Yang, J., Wencewicz, T. A., & Gulick, A. M. (2024). Expanding the Substrate Selectivity of the Fimsbactin Biosynthetic Adenylation Domain, FbsH. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00512

Vancouver

Ahmed SF, Balutowski A, Yang J, Wencewicz TA, Gulick AM. Expanding the Substrate Selectivity of the Fimsbactin Biosynthetic Adenylation Domain, FbsH. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00512

BibTeX
@article{Ahmed2024,
  author = {Ahmed, Syed Fardin and Balutowski, Adam and Yang, Jinping and Wencewicz, Timothy A and Gulick, Andrew M},
  title = {Expanding the Substrate Selectivity of the Fimsbactin Biosynthetic Adenylation Domain, FbsH},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.4c00512}
}
Start for free →